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It is like asking a carpenter what his field
is and getting the reply, “hammer” or “saw”
or “screwdriver”. But what do you build?
What do you create? Even if such questions
did occur to scientists, the problem to be
solved would require such a wide variety of
techniques and encroach on so many areas
of specialization that, through the peer-
review system, it could never be funded. 
This means unfortunately that anyone
with Greene’s “generalized curiosity” is now
unable to prosper in science. In the near
future, those who go in and stay in will
mainly be those with such limited thinking
ability that nothing scientifically really new
will ever be discovered. Is that what
everyone wants? 
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Sir — I disagree with Greene’s main
conclusions. In my opinion, the main
impediment in discussing areas of research
other than our own is the knowledge that
we do not know enough. While I am giving
classes about CD4-gp120 interactions and
CCR5/CXCR4 discrimination of HIV
tropism, new receptors are being described
and my knowledge seems completely
outdated. 
The ‘information network’ is so immense
that we do not have time to read all about
our narrow specialities, much less related
areas, and still do our own research. And
the pressure to publish is still increasing, the
number of reviews published appears to me
to be decreasing, and my ignorance of results
from other areas of research stupefying. 
Working in research I do not like being
‘outdated’ or simply wrong, so I avoid
public statement of opinions.
Vera Bongertz 
Lab AIDS & Molecular Immunology, 
Oswaldo Cruz Foundation, 




Sir — The nomenclature of genes and
proteins in molecular and developmental
biology, as discussed in a recent leading
article in Nature1, is often illogical and
confusing. This problem is sometimes
compounded when two proteins without
any structural and functional relationship
receive the same designation. 
In a recent publication by Pan et al.2,
for example, the authors describe the
cloning and characterization of a new
membrane-anchored chemokine and
propose the name “neurotactin” for this
type of molecule. 
The term “neurotactin” was, however,
used previously to describe a Drosophila
membrane protein with an extracellular
serine esterase-type protein domain which
is dynamically expressed by neuroblasts and
other tissues in the fly embryo3,4. Drosophila
neurotactin has no sequence or functional
similarity to the molecule characterized by
Pan et al.2.
As a solution to such problems, journals
should require the authors of manuscripts
in which new names or terms are proposed
to carry out a computer literature search. 
In the case described above, a Medline
search would have revealed the duplication
and avoided possible confusion to some
readers. Luckily, the CX3C membrane-
bound chemokine described by Pan et al.2 is
identical to a molecule for which Bazan et
al.5 proposed the name “fractalkline”, so an
alternative designation is available.
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